Smolen, J. S. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631–637 (2010).
Google Scholar
Smolen, J. S. et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann. Rheum. Dis. 75, 3–15 (2016).
Google Scholar
Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann. Rheum. Dis. 82, 3–18 (2023).
Google Scholar
Nagy, G. et al. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann. Rheum. Dis. 80, 31–35 (2021).
Google Scholar
National Human Genome Research Institute. Precision medicine https://www.genome.gov/genetics-glossary/Precision-Medicine (2025).
Johnson, K. B. et al. Precision medicine, AI, and the future of personalized health care. Clin. Transl. Sci. 14, 86–93 (2021).
Google Scholar
Grigor, C. et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364, 263–269 (2004).
Google Scholar
Ramiro, S. et al. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM). Ann. Rheum. Dis. 79, 453–459 (2020).
Google Scholar
Hofman, Z. L. M. et al. Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn? Rheumatology 64, 65–73 (2024).
Google Scholar
Nagy, G. et al. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Ann. Rheum. Dis. 81, 20–33 (2022).
Google Scholar
Dey, M., Nagy, G. & Nikiphorou, E. Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin? Rheumatology 62, 1773–1779 (2023).
Google Scholar
Fritsch, K. et al. Screening for rheumatoid arthritis-associated interstitial lung disease using low-dose CT: an emerging approach — an observational prospective case-control study. Arthritis Res. Ther. 27, 208 (2025).
Google Scholar
Tarjanyi, Z. et al. Subclinical myocardial changes in rheumatoid arthritis: cardiovascular magnetic resonance evidence of immuno-inflammatory remodeling. Front. Cardiovasc. Med. 12, 1607018 (2025).
Google Scholar
Nagy, G., Gunkl-Tóth, L., Dorgó, A. M. & McInnes, I. B. The concept of difficult-to-treat disease in rheumatology: where next? Lancet Rheumatol. 7, e274–e289 (2025).
Google Scholar
Luciano, N. et al. Obesity and fibromyalgia are associated with difficult-to-treat rheumatoid arthritis (D2T-RA) independent of age and gender. Arthritis Res. Ther. 27, 2 (2025).
Google Scholar
David, P. et al. Poly-refractory rheumatoid arthritis: an uncommon subset of difficult to treat disease with distinct inflammatory and noninflammatory phenotypes. Arthritis Rheumatol. 76, 510–521 (2024).
Google Scholar
Vasconcelos, C., Kallenberg, C. & Shoenfeld, Y. Refractory disease in autoimmune diseases. Autoimmun. Rev. 10, 653–654 (2011).
Google Scholar
Garcia-Salinas, R. et al. Difficult-to-manage axial spondyloarthritis according to ASAS criteria in Reuma-Check cohort: frequency, predictive factors, and treatment patterns. Clin. Rheumatol. 44, 3959–3965 (2025).
Google Scholar
Poddubnyy, D. et al. The assessment of spondyloarthritis international society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis. Ann. Rheum. Dis. 84, 538–546 (2025).
Google Scholar
Buch, M. H., Eyre, S. & McGonagle, D. Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis. Nat. Rev. Rheumatol. 17, 17–33 (2021).
Google Scholar
Nagy, G. & Buch, M. H. Strengths and limitations of the EULAR definition for difficult-to-treat rheumatoid arthritis. RMD Open 11, e006271 (2025).
Google Scholar
Sarzi-Puttini, P., Zen, M., Arru, F., Giorgi, V. & Choy, E. A. Residual pain in rheumatoid arthritis: is it a real problem? Autoimmun. Rev. 22, 103423 (2023).
Google Scholar
Nerviani, A. et al. A pauci-immune synovial pathotype predicts inadequate response to TNFα-blockade in rheumatoid arthritis patients. Front. Immunol. 11, 845 (2020).
Google Scholar
Orange, D. E. et al. Identification of three rheumatoid arthritis disease subtypes by machine learning integration of synovial histologic features and RNA sequencing data. Arthritis Rheumatol. 70, 690–701 (2018).
Google Scholar
Smith, M. H. et al. Characterizing molecular targets in difficult-to-treat rheumatoid arthritis. Semin. Arthritis Rheum. 70 (Suppl.), 152588 (2025).
Google Scholar
Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616–624 (2023).
Google Scholar
Humby, F. et al. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. Ann. Rheum. Dis. 78, 761–772 (2019).
Google Scholar
Lliso-Ribera, G. et al. Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the Pathobiology of Early Arthritis Cohort (PEAC). Ann. Rheum. Dis. 78, 1642–1652 (2019).
Google Scholar
Bai, Z. et al. Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis. Sci. Transl. Med. 16, eadk3506 (2024).
Google Scholar
Schrepf, A. et al. A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis. Nat. Commun. 9, 2243 (2018).
Google Scholar
Basu, N. et al. Neurobiologic features of fibromyalgia are also present among rheumatoid arthritis patients. Arthritis Rheumatol. 70, 1000–1007 (2018).
Google Scholar
El-Kasmi, H. et al. The prevalence of fibromyalgia in rheumatoid arthritis patients using the fibromyalgia assessment screening tool (FAST 4) based on the multidimensional health assessment questionnaire (MDHAQ). Cureus 16, e64011 (2024).
Google Scholar
Sheng, J., Liu, S., Wang, Y., Cui, R. & Zhang, X. The link between depression and chronic pain: neural mechanisms in the brain. Neural Plast. 2017, 9724371 (2017).
Google Scholar
van der Heijde, D. M. et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann. Rheum. Dis. 49, 916–920 (1990).
Google Scholar
Smolen, J. S. et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 42, 244–257 (2003).
Google Scholar
Aletaha, D. et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res. Ther. 7, R796–R806 (2005).
Google Scholar
Colebatch, A. N. et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann. Rheum. Dis. 72, 804–814 (2013).
Google Scholar
Canhão, H. et al. Common evaluations of disease activity in rheumatoid arthritis each discordant classifications across different populations. Front. Med. 5, 40 (2018).
Google Scholar
Johnson, T. M., Michaud, K. & England, B. R. Measures of rheumatoid arthritis disease activity. Arthritis Care Res. 72, 4–26 (2020).
Google Scholar
Santos, I. A. et al. Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study. PLoS ONE 17, e0273789 (2022).
Google Scholar
McWilliams, D. F. et al. Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis. BMC Rheumatol. 2, 8 (2018).
Google Scholar
Pincus, T., Li, T. & Gibson, K. A. Elevated DAS28, CDAI, RAPID3 and five of seven RA core data set measures in patients with positive screens for anxiety, depression or fibromyalgia on an MDHAQ. Rheumatology 64, 4555–4564 (2025).
Google Scholar
Lee, S. W., Kim, S. Y. & Chang, S. H. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study. BMC Musculoskelet. Disord. 20, 420 (2019).
Google Scholar
Simonsen, M. B., Hørslev-Petersen, K., Cöster, M. C., Jensen, C. & Bremander, A. Foot and ankle problems in patients with rheumatoid arthritis in 2019: still an important issue. ACR Open Rheumatol. 3, 396–402 (2021).
Google Scholar
Dale, J. et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann. Rheum. Dis. 75, 1043–1050 (2016).
Google Scholar
Haavardsholm, E. A. et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ 354, i4205 (2016).
Google Scholar
Møller-Bisgaard, S. et al. Effect of magnetic resonance imaging vs conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis: the IMAGINE-RA randomized clinical trial. JAMA 321, 461–472 (2019).
Google Scholar
Terslev, L. et al. Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors. RMD Open 8, e002796 (2022).
Google Scholar
Añez, G. et al. Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool? J. Ultrasound 28, 81–87 (2025).
Google Scholar
Roodenrijs, N. M. T. et al. Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search. Rheumatology 61, 3552–3566 (2022).
Google Scholar
Lin, C. M. A., Cooles, F. A. H. & Isaacs, J. D. Precision medicine: the precision gap in rheumatic disease. Nat. Rev. Rheumatol. 18, 725–733 (2022).
Google Scholar
McGonagle, D., Watad, A. & Savic, S. Mechanistic immunological based classification of rheumatoid arthritis. Autoimmun. Rev. 17, 1115–1123 (2018).
Google Scholar
Gudu, T., Oztas, M. & Nikiphorou, E. Contemporary approaches to the management of rheumatoid arthritis: precision and progress. Best. Pract. Res. Clin. Rheumatol. 39, 102106 (2025).
Google Scholar
Avouac, J., Kay, J. & Choy, E. Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges. Semin. Arthritis Rheum. 73, 152740 (2025).
Google Scholar
Cuppen, B. V. et al. Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability. Rheumatology 55, 826–839 (2016).
Google Scholar
Tweehuysen, L. et al. Little evidence for usefulness of biomarkers for predicting successful dose reduction or discontinuation of a biologic agent in rheumatoid arthritis: a systematic review. Arthritis Rheumatol. 69, 301–308 (2017).
Google Scholar
Wientjes, M. H. M., den Broeder, A. A., Welsing, P. M. J., Verhoef, L. M. & van den Bemt, B. J. F. Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review. RMD Open 8, e002570 (2022).
Google Scholar
Neto, M., Mendes, B., Albuquerque, F. & da Silva, J. A. P. Novel biomarkers in RA: implication for diagnosis, prognosis, and personalised treatment. Best Pract. Res. Clin. Rheumatol. 39, 102021 (2025).
Google Scholar
Koo, B. S. et al. Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics. Arthritis Res. Ther. 23, 178 (2021).
Google Scholar
Li, G. et al. Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study. Front. Med. 12, 1526708 (2025).
Google Scholar
Norgeot, B. et al. Assessment of a deep learning model based on electronic health record data to forecast clinical outcomes in patients with rheumatoid arthritis. JAMA Netw. Open 2, e190606 (2019).
Google Scholar
Benavent, D. et al. Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review. Rheumatol. Int. 45, 91 (2025).
Google Scholar
Shi, Y. et al. Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management. Front. Immunol. 15, 1409555 (2024).
Google Scholar
Baloun, J. et al. Machine learning-assisted screening of clinical features for predicting difficult-to-treat rheumatoid arthritis. Sci. Rep. 15, 34747 (2025).
Google Scholar
Paudel, M. L. et al. Development and external validation of a multivariable predictive model for progression to difficult-to-treat rheumatoid arthritis in biologic-experienced patients. Arthritis Care Res. 78, 54–65 (2026).
Google Scholar
Watanabe, R. et al. Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study. Rheumatology 63, 2418–2426 (2024).
Google Scholar
Santosa, A., Li, J. W. & Tan, T. C. Randomized controlled trials of digital health interventions for rheumatic disease management: a systematic review. Bull. World Health Organ. 103, 136–147 (2025).
Google Scholar
Jackson, L. E. et al. Telemedicine in rheumatology care: a systematic review. Semin. Arthritis Rheum. 56, 152045 (2022).
Google Scholar
Gandrup, J., Selby, D. A., van der Veer, S. N., McBeth, J. & Dixon, W. G. Using patient-reported data from a smartphone app to capture and characterize real-time patient-reported flares in rheumatoid arthritis. Rheumatol. Adv. Pract. 6, rkac021 (2022).
Google Scholar
Pers, Y.-M. et al. A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis. Rheumatology 60, 1659–1668 (2020).
Google Scholar
Athieniti, E. & Spyrou, G. M. A guide to multi-omics data collection and integration for translational medicine. Comput. Struct. Biotechnol. J. 21, 134–149 (2023).
Google Scholar
Stoffer, M. A. et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann. Rheum. Dis. 75, 16–22 (2016).
Google Scholar
